Logo image of KRMD

KORU MEDICAL SYSTEMS INC (KRMD) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:KRMD - US7599101026 - Common Stock

5.8 USD
+0.55 (+10.48%)
Last: 11/26/2025, 8:00:02 PM
5.8 USD
0 (0%)
After Hours: 11/26/2025, 8:00:02 PM
Fundamental Rating

3

KRMD gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 188 industry peers in the Health Care Equipment & Supplies industry. While KRMD seems to be doing ok healthwise, there are quite some concerns on its profitability. KRMD is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year KRMD has reported negative net income.
In the past year KRMD has reported a negative cash flow from operations.
KRMD had negative earnings in each of the past 5 years.
In the past 5 years KRMD always reported negative operating cash flow.
KRMD Yearly Net Income VS EBIT VS OCF VS FCFKRMD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M

1.2 Ratios

KRMD has a Return On Assets (-17.69%) which is comparable to the rest of the industry.
KRMD has a Return On Equity (-27.32%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -17.69%
ROE -27.32%
ROIC N/A
ROA(3y)-30.34%
ROA(5y)-21.02%
ROE(3y)-43.74%
ROE(5y)-29.41%
ROIC(3y)N/A
ROIC(5y)N/A
KRMD Yearly ROA, ROE, ROICKRMD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

1.3 Margins

KRMD's Gross Margin of 63.15% is fine compared to the rest of the industry. KRMD outperforms 64.36% of its industry peers.
KRMD's Gross Margin has been stable in the last couple of years.
KRMD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 63.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.65%
GM growth 5Y-0.23%
KRMD Yearly Profit, Operating, Gross MarginsKRMD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

5

2. Health

2.1 Basic Checks

KRMD does not have a ROIC to compare to the WACC, probably because it is not profitable.
KRMD has more shares outstanding than it did 1 year ago.
The number of shares outstanding for KRMD has been increased compared to 5 years ago.
The debt/assets ratio for KRMD has been reduced compared to a year ago.
KRMD Yearly Shares OutstandingKRMD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
KRMD Yearly Total Debt VS Total AssetsKRMD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

KRMD has an Altman-Z score of 17.57. This indicates that KRMD is financially healthy and has little risk of bankruptcy at the moment.
KRMD's Altman-Z score of 17.57 is amongst the best of the industry. KRMD outperforms 94.15% of its industry peers.
A Debt/Equity ratio of 0.01 indicates that KRMD is not too dependend on debt financing.
KRMD has a Debt to Equity ratio of 0.01. This is in the better half of the industry: KRMD outperforms 71.81% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 17.57
ROIC/WACCN/A
WACC8.65%
KRMD Yearly LT Debt VS Equity VS FCFKRMD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

KRMD has a Current Ratio of 2.91. This indicates that KRMD is financially healthy and has no problem in meeting its short term obligations.
KRMD has a Current ratio (2.91) which is in line with its industry peers.
A Quick Ratio of 2.25 indicates that KRMD has no problem at all paying its short term obligations.
KRMD has a Quick ratio (2.25) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 2.91
Quick Ratio 2.25
KRMD Yearly Current Assets VS Current LiabilitesKRMD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

5

3. Growth

3.1 Past

KRMD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 30.00%, which is quite impressive.
Looking at the last year, KRMD shows a quite strong growth in Revenue. The Revenue has grown by 17.98% in the last year.
Measured over the past years, KRMD shows a small growth in Revenue. The Revenue has been growing by 7.76% on average per year.
EPS 1Y (TTM)30%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
Revenue 1Y (TTM)17.98%
Revenue growth 3Y12.72%
Revenue growth 5Y7.76%
Sales Q2Q%27.18%

3.2 Future

Based on estimates for the next years, KRMD will show a very strong growth in Earnings Per Share. The EPS will grow by 30.14% on average per year.
The Revenue is expected to grow by 16.30% on average over the next years. This is quite good.
EPS Next Y18.4%
EPS Next 2Y32.48%
EPS Next 3Y30.14%
EPS Next 5YN/A
Revenue Next Year18.53%
Revenue Next 2Y17.44%
Revenue Next 3Y16.3%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
KRMD Yearly Revenue VS EstimatesKRMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M 50M
KRMD Yearly EPS VS EstimatesKRMD Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.05 -0.1 -0.15 -0.2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

KRMD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for KRMD. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KRMD Price Earnings VS Forward Price EarningsKRMD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150 -200

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KRMD Per share dataKRMD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

KRMD's earnings are expected to grow with 30.14% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.48%
EPS Next 3Y30.14%

More info and screens

0

5. Dividend

5.1 Amount

KRMD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

KORU MEDICAL SYSTEMS INC

NASDAQ:KRMD (11/26/2025, 8:00:02 PM)

After market: 5.8 0 (0%)

5.8

+0.55 (+10.48%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-12 2025-11-12/amc
Earnings (Next)N/A N/A
Inst Owners55.68%
Inst Owner ChangeN/A
Ins Owners8.29%
Ins Owner Change1.57%
Market Cap268.13M
Revenue(TTM)33.65M
Net Income(TTM)-4.51M
Analysts80
Price Target5.76 (-0.69%)
Short Float %1.95%
Short Ratio8.31
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)62.29%
Min EPS beat(2)24.59%
Max EPS beat(2)100%
EPS beat(4)4
Avg EPS beat(4)37.77%
Min EPS beat(4)3.88%
Max EPS beat(4)100%
EPS beat(8)8
Avg EPS beat(8)40.05%
EPS beat(12)12
Avg EPS beat(12)34.3%
EPS beat(16)15
Avg EPS beat(16)29.18%
Revenue beat(2)2
Avg Revenue beat(2)6.08%
Min Revenue beat(2)5.66%
Max Revenue beat(2)6.5%
Revenue beat(4)3
Avg Revenue beat(4)3.5%
Min Revenue beat(4)-2.56%
Max Revenue beat(4)6.5%
Revenue beat(8)6
Avg Revenue beat(8)2.35%
Revenue beat(12)7
Avg Revenue beat(12)1.68%
Revenue beat(16)11
Avg Revenue beat(16)2.34%
PT rev (1m)0.89%
PT rev (3m)0.89%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-7.69%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.23%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 7.28
P/FCF N/A
P/OCF N/A
P/B 16.22
P/tB 16.94
EV/EBITDA N/A
EPS(TTM)-0.07
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.8
BVpS0.36
TBVpS0.34
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -17.69%
ROE -27.32%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 63.15%
FCFM N/A
ROA(3y)-30.34%
ROA(5y)-21.02%
ROE(3y)-43.74%
ROE(5y)-29.41%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.65%
GM growth 5Y-0.23%
F-Score5
Asset Turnover1.44
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 177.3%
Cap/Sales 4.17%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.91
Quick Ratio 2.25
Altman-Z 17.57
F-Score5
WACC8.65%
ROIC/WACCN/A
Cap/Depr(3y)239.72%
Cap/Depr(5y)210.83%
Cap/Sales(3y)5.63%
Cap/Sales(5y)4.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
EPS Next Y18.4%
EPS Next 2Y32.48%
EPS Next 3Y30.14%
EPS Next 5YN/A
Revenue 1Y (TTM)17.98%
Revenue growth 3Y12.72%
Revenue growth 5Y7.76%
Sales Q2Q%27.18%
Revenue Next Year18.53%
Revenue Next 2Y17.44%
Revenue Next 3Y16.3%
Revenue Next 5YN/A
EBIT growth 1Y32.08%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year95.4%
EBIT Next 3Y43.64%
EBIT Next 5YN/A
FCF growth 1Y67.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y87.78%
OCF growth 3YN/A
OCF growth 5YN/A

KORU MEDICAL SYSTEMS INC / KRMD FAQ

What is the ChartMill fundamental rating of KORU MEDICAL SYSTEMS INC (KRMD) stock?

ChartMill assigns a fundamental rating of 3 / 10 to KRMD.


What is the valuation status of KORU MEDICAL SYSTEMS INC (KRMD) stock?

ChartMill assigns a valuation rating of 1 / 10 to KORU MEDICAL SYSTEMS INC (KRMD). This can be considered as Overvalued.


Can you provide the profitability details for KORU MEDICAL SYSTEMS INC?

KORU MEDICAL SYSTEMS INC (KRMD) has a profitability rating of 1 / 10.


How financially healthy is KORU MEDICAL SYSTEMS INC?

The financial health rating of KORU MEDICAL SYSTEMS INC (KRMD) is 5 / 10.